A Study of KK2223 in People With T-cell NonHodgkin Lymphoma

Full Title

A Phase 1, Multicenter, Open-label, Non-randomized, Dose-escalation and Backfill Study of KK2223 in Participants with Relapsed or Refractory T-cell Non-Hodgkin Lymphoma

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Jasmine Zain’s office at 646-608-4394.

Protocol
26-223
Phase
Phase I (phase 1)
Disease Status
Relapsed or Refractory
Investigator
Jasmine M. Zain
Co-Investigators
Steven M. Horwitz
Diseases
Lymphoma › Non-Hodgkin's Lymphoma
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07192471
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description